>In biotech, “regains product rights” is a euphemism for getting dumped by a partner.<
speaking of euphemisms, from today's oncy pr:
"Toxicities possibly related to REOLYSIN® treatment in this trial have generally been mild (grade 1 or 2) and have included chills, fever, headache, cough, runny nose, sore throat and fatigue. Transient grade 3 toxicities include lymphopenia, neutropenia and troponin I. These symptoms were more frequently observed from day two of treatment and usually lasted less than six hours."
Troponin I is a euphemism for infarction / death of cardiomyocytes. In other words, juuuuust a touch of a heart attack. But I guess that wouldn't sound as benign now would it?
If I was working at a large banking firm, i'd short oncy and come back in a decade. Guaranteed profit, imo.